drugset / Trial / NCT03860506

Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke

NCT03860506 ↗

Phase 1 Completed 30 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

This is a single dose inpatient and outpatient study to test whether an effect on the ability of platelets to stick to white blood cells in subjects who smoke.

Timeline

Start
2008-04-01
Primary completion
2008-07-01
Completion
2008-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject PSI-697 Small molecule — Oral

Indications

No indication recorded.